Healthcare provider profile · identity verified

Lucas H Hintermeister, MD

Family Practice · CAMBRIDGE, MN · NPI 1124114608

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Buprenorphine-Naloxone	Buprenorphine Hcl/Naloxone Hcl	234	23
Lisinopril	Lisinopril	230	58
Atorvastatin Calcium	Atorvastatin Calcium	227	57
Omeprazole	Omeprazole	195	50
Amlodipine Besylate	Amlodipine Besylate	177	47
Albuterol Sulfate Hfa	Albuterol Sulfate	156	34
Levothyroxine Sodium	Levothyroxine Sodium	115	27
Metformin Hcl Er	Metformin Hcl	112	26
Gabapentin	Gabapentin	109	30
Glipizide	Glipizide	107	21
Hydrochlorothiazide	Hydrochlorothiazide	99	22
Tamsulosin Hcl	Tamsulosin Hcl	96	24
Simvastatin	Simvastatin	93	23
Metformin Hcl	Metformin Hcl	91	20
Furosemide	Furosemide	86	22
Tramadol Hcl	Tramadol Hcl	86	12
Zolpidem Tartrate	Zolpidem Tartrate	86	14
Losartan Potassium	Losartan Potassium	84	22
Metoprolol Tartrate	Metoprolol Tartrate	80	21
Pantoprazole Sodium	Pantoprazole Sodium	77	18
Famotidine	Famotidine	75	18
Rosuvastatin Calcium	Rosuvastatin Calcium	75	20
Metoprolol Succinate	Metoprolol Succinate	72	24
Clonazepam	Clonazepam	68	suppressed
Trazodone Hcl	Trazodone Hcl	68	19
Suboxone	Buprenorphine Hcl/Naloxone Hcl	56	suppressed
Lovastatin	Lovastatin	54	13
Fluoxetine Hcl	Fluoxetine Hcl	53	suppressed
Allopurinol	Allopurinol	52	14
Topiramate	Topiramate	52	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	51	suppressed
Azelastine Hcl	Azelastine Hcl	48	20
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	12
Sertraline Hcl	Sertraline Hcl	47	14
Fluticasone Propionate	Fluticasone Propionate	46	19
Citalopram Hbr	Citalopram Hydrobromide	45	11
Spironolactone	Spironolactone	44	suppressed
Alprazolam	Alprazolam	43	suppressed
Duloxetine Hcl	Duloxetine Hcl	43	13
Oxycodone Hcl	Oxycodone Hcl	41	12
Montelukast Sodium	Montelukast Sodium	40	13
Buprenorphine Hcl	Buprenorphine Hcl	39	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	39	suppressed
Eliquis	Apixaban	38	suppressed
Warfarin Sodium	Warfarin Sodium	38	13
Dextroamphetamine-Amphet Er	Dextroamphetamine/Amphetamine	36	suppressed
Prednisone	Prednisone	35	25
Mirtazapine	Mirtazapine	34	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	34	suppressed
Ventolin Hfa	Albuterol Sulfate	34	13
Amitriptyline Hcl	Amitriptyline Hcl	32	suppressed
Tizanidine Hcl	Tizanidine Hcl	31	suppressed
Incruse Ellipta	Umeclidinium Bromide	29	suppressed
Potassium Chloride	Potassium Chloride	29	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	28	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Atenolol	Atenolol	26	suppressed
Ozempic	Semaglutide	26	suppressed
Aripiprazole	Aripiprazole	25	suppressed
Ibuprofen	Ibuprofen	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	23	suppressed
Chlorthalidone	Chlorthalidone	22	suppressed
Clonidine Hcl	Clonidine Hcl	22	suppressed
Constulose	Lactulose	22	suppressed
Levetiracetam	Levetiracetam	22	suppressed
Carvedilol	Carvedilol	21	suppressed
Novolog Flexpen	Insulin Aspart	21	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Baclofen	Baclofen	20	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	20	16
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	20	suppressed
Pravastatin Sodium	Pravastatin Sodium	20	suppressed
Savella	Milnacipran Hcl	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	18	suppressed
Klor-Con M10	Potassium Chloride	17	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	17	suppressed
Divalproex Sodium Er	Divalproex Sodium	16	suppressed
Glipizide Er	Glipizide	16	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	16	suppressed
Xarelto	Rivaroxaban	16	suppressed
Alendronate Sodium	Alendronate Sodium	15	suppressed
Bupropion Hcl Sr	Bupropion Hcl	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	15	suppressed
Levalbuterol Tartrate Hfa	Levalbuterol Tartrate	15	suppressed
Nystatin	Nystatin	15	suppressed
Paroxetine Hcl	Paroxetine Hcl	15	suppressed
Propranolol Hcl	Propranolol Hcl	15	suppressed
Toujeo Max Solostar	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	15	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	14	suppressed
Clopidogrel	Clopidogrel Bisulfate	14	suppressed
Dulera	Mometasone/Formoterol	14	suppressed
Jardiance	Empagliflozin	14	suppressed
Metolazone	Metolazone	14	suppressed
Myrbetriq	Mirabegron	14	suppressed
Rizatriptan	Rizatriptan Benzoate	14	suppressed
Bupropion Xl	Bupropion Hcl	13	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	13	suppressed
Humalog	Insulin Lispro	13	suppressed
Ketoconazole	Ketoconazole	13	suppressed
Lorazepam	Lorazepam	13	suppressed
Zubsolv	Buprenorphine Hcl/Naloxone Hcl	13	suppressed
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	12	suppressed
Cephalexin	Cephalexin	12	suppressed
Desmopressin Acetate	Desmopressin Acetate	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	12	suppressed
Spiriva Handihaler	Tiotropium Bromide	12	suppressed
Synthroid	Levothyroxine Sodium	12	suppressed
Irbesartan	Irbesartan	11	suppressed
Meclizine Hcl	Meclizine Hcl	11	suppressed
Mounjaro	Tirzepatide	11	suppressed
Nitroglycerin	Nitroglycerin	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error